Catalyst Wire Dossier Catalyst Wire Dossier

GS1168

GS1168 · Gritgen Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS1168, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria [EARLY_Phase 1]

See pricing